Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

Completed · Phase 2

Conditions studied: Multiple Myeloma, Plasma Cell Neoplasm

In brief

RATIONALE: Peripheral blood stem cell transplant using stem cells from the patient or a donor may be able to replace immune cells that were destroyed by chemotherapy used to kill tumor cells. The donated stem cells may also help destroy any remaining cancer cells (graft-versus-tumor effect). PURPOSE: This phase II trial is studying how well autologous peripheral stem cell transplant followed by donor peripheral stem cell transplant works in treating patients with multiple myeloma.

Key facts

Study ID
NCT00028600
Run by
Alliance for Clinical Trials in Oncology
People needed
60
Starts
2001-11-01
Expected to finish
2010-02-01
Last updated by the study team
2016-07-04

Who can join

Age: any, up to 64. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.